PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

Averoa, a biopharmaceutical company bringing innovative therapeutic solutions to people with renal diseases, today announces a positive opinion from the European Medicines Agency (EMA)’s Committee for ...

Last week, the Medicines and Healthcare products Regulatory Agency hosted a landmark event in Westminster, London, to ...

A NEW type of ‘Botox’ that works almost instantly and lasts over half a year is set to hit UK clinics as early as next month.

CHMP recommends approval for XOANACYL, an oral therapy for use in the following therapeutic areas: Iron deficiency, chronic renal failure and ...

The U.K. Medicines and Healthcare Products Regulatory Agency (MHRA) unveiled the pilot version of its AI Airlock in 2024, and the agency posted a list of the products that are taking part in this ...

Maine has refused to comply with President Donald Trump’s executive order to keep biological males from competing in girls’ ...

The MHRA has approved the product for three clinical settings, including identifying how far high-risk prostate cancer has ...

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with ...

Maine Sen. Susan Collins said in a statement that she doesn't believe "transgender athletes should compete in girls’ and ...

On March 17, 2025, the government published a policy paper with an Action Plan for regulation and regulators, outlining how it intends to reform ...